Mathi Rave-Indranathan

Mathi Rave-Indranathan has a diverse work experience in the finance and accounting field. They most recently served as the Senior Director of Finance at Prime Medicine, Inc. starting in April 2023. Prior to that, Mathi worked at C4 Therapeutics, Inc. as the Corporate Controller from September 2021 to March 2023, and as the Director of Accounting and SEC Reporting from November 2020 to August 2021. They also held the position of Director of Financial Reporting and Technical Accounting at Beam Therapeutics from November 2019 to November 2020. Earlier in their career, Mathi worked at Agios Pharmaceuticals in various roles, including Associate Director of Financial Reporting and Technical Accounting from January 2019 to November 2019, Senior Manager of Financial Reporting and Technical Accounting from January 2016 to December 2018, and Manager of Financial Reporting and Technical Accounting from June 2014 to December 2015. Mathi's experience also includes a role as the Manager of Global Accounting Policies at State Street from July 2013 to June 2014. They began their career at Deloitte, where they worked as an Audit Manager from August 2012 to July 2013, an Audit Senior from August 2009 to July 2012, and an Audit Staff from August 2007 to July 2009.

Mathi Rave-Indranathan completed a Bachelor of Science in Business Administration (BSBA) in Accounting and Finance at Northeastern University from 2003 to 2007. Subsequently, Mathi pursued a Master of Science in Accounting (MSA) at the Boston College Carroll School of Management from 2007 to 2008. Additionally, Mathi holds a certification as a Certified Public Accountant from the Commonwealth of Massachusetts; however, the specific month and year of obtaining the certification are not provided.